|
|
|
|
| LEADER |
02737nam a2200553 4500 |
| 001 |
on1041853296 |
| 003 |
OCoLC |
| 005 |
20200326101154.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
180625s2018 mau ob 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d OPELS
|d OCLCF
|d OHS
|d OCLCO
|d UPM
|d NLE
|d UKMGB
|d OCLCA
|d D6H
|d GrThAP
|
| 015 |
|
|
|a GBB8C8842
|2 bnb
|
| 016 |
7 |
|
|a 018924395
|2 Uk
|
| 020 |
|
|
|a 9780128141700
|q (electronic bk.)
|
| 020 |
|
|
|a 0128141700
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128141694
|
| 035 |
|
|
|a (OCoLC)1041853296
|
| 050 |
|
4 |
|a R857.N34
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.9940642
|2 23
|
| 245 |
0 |
0 |
|a Advances in cancer research.
|n Volume 139.
|p Cancer nanotechnology.
|
| 246 |
3 |
0 |
|a Cancer nanotechnology.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press,
|c 2018.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed June 26, 2018)
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 520 |
|
|
|a Advances in Cancer Research, Volume 139, provides invaluable information on the exciting and fast-moving field of cancer research. Original reviews are presented on a variety of topics relating to the rapidly developing intersection between nanotechnology and cancer research, with unique sections in the new release focusing on Exosomes as a theranostic for lung cancer, Nanotechnology and cancer immunotherapy, Ultrasound imaging agents and delivery systems, Dendronized systems for the delivery of chemotherapeutics, Thermosensitive liposomes for image-guided drug delivery, Supramolecular Chemistry in Tumor Analysis and Drug Delivery, Gold nanoparticles for delivery of cancer therapeutics, and Single cell barcode microchip for cancer research and therapy.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
0 |
|a Cancer
|x Treatment.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Cancer
|x Treatment.
|2 fast
|0 (OCoLC)fst00845538
|
| 650 |
|
7 |
|a Nanomedicine.
|2 fast
|0 (OCoLC)fst01744350
|
| 650 |
|
2 |
|a Neoplasms.
|
| 650 |
|
2 |
|a Nanotechnology.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Broome, Ann-Marie.
|
| 856 |
4 |
0 |
|3 ScienceDirect
|u https://www.sciencedirect.com/science/bookseries/0065230X/139
|z Full Text via HEAL-Link
|
